Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

US Patent 10082496 · Granted Sep 25, 2018

Assignee

Inventors

View full patent text on Google Patents →